Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

floWteiuQ

Send PM
Followers 1
Posts 94
Boards Moderated 0
Alias Born 10/12/2013

floWteiuQ

Re: None

Thursday, 09/15/2016 11:07:30 AM

Thursday, September 15, 2016 11:07:30 AM

Post# of 80490
Interesting CML science, but mentioning only Epizyme, next target after Ariad.

http://medicalxpress.com/news/2016-09-prospect-shorter-treatment-chronic-myelogenous.html
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next